Low Protein Diet, Gut Microbiome and Chronic Kidney Disease
Exploring the Role of Low Protein Diet on the Gut Microbiome, Related Metabolites and Renal Function in Chronic Kidney Disease
1 other identifier
interventional
100
1 country
1
Brief Summary
Chronic kidney disease (CKD) is a worldwide public health dilemma because of close association with multiple comorbidities, demanding high cardiovascular events, mortality and expensive medical cost. Novel and effective therapeutic measures remain urgently needed to reduce burden and impact of disease. Advanced renal failure can profoundly alter the biochemical milieu of the gastrointestinal tract leading to a leak gut. Application of 16s rRNA gene analysis identified an increase of Clostridia, Actinobacteria, and Gammaproteobacteria in hemodialysis patients and decrease of Bifidobacterium and lactobacillus in peritoneal patients. This altered microbiome consequently affect production of indole or phenol derived uremic toxins leading to renal damage. Our preliminary results indicated reduced number and diversity of intestinal microbes CKD patients compared to normal. Different dietary nutrients can affect the gut microbiome and derive several deleterious metabolites leading to metabolic disarrangement. Clinically, low-protein diet should be prescribe to renal patients to preserve renal function and high fat content are usually recommended to avoid caloric malnutrition to dietary restriction. The changes of diet-microbiome-metabolite interaction are large unknown with this dietary manipulation. The aims of this study is to determine the renal progression-associated gene and taxonomic alterations bymetagenome-wide association studies and the functional characterization of gut microbiome in CKD patients receiving different low-protein or high-fat diets. The results of the study will provide insight on the exact role of dietary manipulation in CKD patients from gut-renal cross talk.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2020
CompletedFirst Submitted
Initial submission to the registry
January 19, 2021
CompletedFirst Posted
Study publicly available on registry
August 25, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2021
CompletedAugust 25, 2021
January 1, 2021
1 year
January 19, 2021
August 20, 2021
Conditions
Outcome Measures
Primary Outcomes (3)
change of gut microbiota
change of relative abundance of microbes
3 months
change of host metabolite concentration
change of concentration of serum metabolomic profile
3 months
change of renal function
serum creatinine, estimated glomerular filtration rate or urine total protein
3 months
Study Arms (3)
normal controls
NO INTERVENTIONsubjects with normal renal function
CKD_Low protein diet
EXPERIMENTALCKD patient with low protein diet (\<0.8g/kg/BW)
CKD_normal protein diet
ACTIVE COMPARATORCKD patient with normal protein diet
Interventions
Eligibility Criteria
You may qualify if:
- Patients aged 30-90 years with diagnosis of CKD (defined as abovementioned).
- Sign the inform consent and agree to participate in this study.
- Compliant to low protein diet (defined as protein intake \<0.8 g/Kg/day) for 4 weeks assessed by 24h urine urea estimates, before enrollment
You may not qualify if:
- History of any malignancy, liver cirrhosis, intestinal operation, irritable bowel syndrome, cardiovascular disease (defined as myocardial infarction, documented Q wave on EKG, unstable angina, coronary artery disease with stenosis \> 75%, congestive heart failure with Ejection Fraction \< 50% and cerebrovascular disease) in the past 3 months.
- History of or infection disease requiring admission in the past 3 months or, concomitant antibiotics use.
- Concomitant use of probiotics or prebiotics.
- Pregnancy.
- Renal transplant recipients.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chang Gung Memorial Hospital
Keelung, 204, Taiwan
Related Publications (1)
Wu IW, Lee CC, Hsu HJ, Sun CY, Chen YC, Yang KJ, Yang CW, Chung WH, Lai HC, Chang LC, Su SC. Compositional and Functional Adaptations of Intestinal Microbiota and Related Metabolites in CKD Patients Receiving Dietary Protein Restriction. Nutrients. 2020 Sep 12;12(9):2799. doi: 10.3390/nu12092799.
PMID: 32932711RESULT
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
I Wen Wu
Chang Gung Memorial Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 19, 2021
First Posted
August 25, 2021
Study Start
August 1, 2019
Primary Completion
July 31, 2020
Study Completion
October 31, 2021
Last Updated
August 25, 2021
Record last verified: 2021-01
Data Sharing
- IPD Sharing
- Will not share